Lpa2 is a negative regulator of both dendritic cell activation and murine models of allergic lung inflammation

Journal of Immunology

Volumn 188, Issue 8, 2012, Pages 3784-3790

  Emo, Jason ^a   Meednu, Nida ^a   Chapman, Timothy J ^a   Rezaee, Fariba ^a   Balys, Marlene ^a   Randall, Troy ^a   Rangasamy, Tirumalai ^a   Georas, Steve N ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDIC ACID 2; OVALBUMIN; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ALLERGIC ASTHMA; ALLERGIC PNEUMONITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVATION; COCULTURE; CONTROLLED STUDY; DENDRITIC CELL; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IN VITRO STUDY; INNATE IMMUNITY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ADMINISTRATION, INHALATION; ADOPTIVE TRANSFER; ALLERGENS; ANIMALS; ASTHMA; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; FEMALE; GENE DELETION; HEK293 CELLS; HUMANS; INFLAMMATION; LUNG; LYSOPHOSPHOLIPIDS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-KAPPA B; RECEPTORS, LYSOPHOSPHATIDIC ACID; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 84860342740     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1102956     Document Type: Article

References (58)

1. Choi, J. W., D. R. Herr, K. Noguchi, Y. C. Yung, C. W. Lee, T. Mutoh, M. E. Lin, S. T. Teo, K. E. Park, A. N. Mosley, and J. Chun. 2010. LPA receptors: subtypes and biological actions. Annu. Rev. Pharmacol. Toxicol. 50: 157-186.
2. Umezu-Goto, M., Y. Kishi, A. Taira, K. Hama, N. Dohmae, K. Takio, T. Yamori, G. B. Mills, K. Inoue, J. Aoki, and H. Arai. 2002. Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. J. Cell Biol. 158: 227-233.
3. van Meeteren, L. A., P. Ruurs, C. Stortelers, P. Bouwman, M. A. van Rooijen, J. P. Pradère, T. R. Pettit, M. J. Wakelam, J. S. Saulnier-Blache, C. L. Mummery, et al. 2006. Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during development. Mol. Cell. Biol. 26: 5015-5022. (Pubitemid 43955815)
4. Fukushima, N., and J. Chun. 2001. The LPA receptors. Prostaglandins 64: 21-32. (Pubitemid 32452279)
5. Hla, T., M. J. Lee, N. Ancellin, J. H. Paik, and M. J. Kluk. 2001. Lysophospholipids-receptor revelations. Science 294: 1875-1878.
6. Choi, J. W., C. W. Lee, and J. Chun. 2008. Biological roles of lysophospholipid receptors revealed by genetic null mice: an update. Biochim. Biophys. Acta 1781: 531-539.
7. Chun, J., T. Hla, K. R. Lynch, S. Spiegel, and W. H. Moolenaar. 2010. International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid receptor nomenclature. Pharmacol. Rev. 62: 579-587.
8. Pyne, N. J., and S. Pyne. 2008. Sphingosine 1-phosphate, lysophosphatidic acid and growth factor signaling and termination. Biochim. Biophys. Acta 1781: 467-476.
9. Panther, E., M. Idzko, S. Corinti, D. Ferrari, Y. Herouy, M. Mockenhaupt, S. Dichmann, P. Gebicke-Haerter, F. Di Virgilio, G. Girolomoni, and J. Norgauer. 2002. The influence of lysophosphatidic acid on the functions of human dendritic cells. J. Immunol. 169: 4129-4135. (Pubitemid 35178182)
10. Gustin, C., M. Van Steenbrugge, and M. Raes. 2008. LPA modulates monocyte migration directly and via LPA-stimulated endothelial cells. Am. J. Physiol. Cell Physiol. 295: C905-C914.
11. Wang, L., E. Knudsen, Y. Jin, S. Gessani, and A. A. Maghazachi. 2004. Lysophospholipids and chemokines activate distinct signal transduction pathways in T helper 1 and T helper 2 cells. Cell. Signal. 16: 991-1000. (Pubitemid 38798050)
12. Lee, Z., C. T. Cheng, H. Zhang, M. A. Subler, J. Wu, A. Mukherjee, J. J. Windle, C. K. Chen, and X. Fang. 2008. Role of LPA4/p2y9/GPR23 in negative regulation of cell motility. Mol. Biol. Cell 19: 5435-5445.
13. Kim, E. K., S. J. Yun, K. H. Do, M. S. Kim, M. Cho, D. S. Suh, C. D. Kim, J. H. Kim, M. J. Birnbaum, and S. S. Bae. 2008. Lysophosphatidic acid induces cell migration through the selective activation of Akt1. Exp. Mol. Med. 40: 445-452.
14. Balazs, L., J. Okolicany, M. Ferrebee, B. Tolley, and G. Tigyi. 2001. Topical application of the phospholipid growth factor lysophosphatidic acid promotes wound healing in vivo. Am. J. Physiol. Regul. Integr. Comp. Physiol. 280: R466-R472.
15. Rivera, R., and J. Chun. 2008. Biological effects of lysophospholipids. Rev. Physiol. Biochem. Pharmacol. 160: 25-46.
16. Stortelers, C., R. Kerkhoven, and W. H. Moolenaar. 2008. Multiple actions of lysophosphatidic acid on fibroblasts revealed by transcriptional profiling. BMC Genomics 9: 387.
17. Estivill-Torrús, G., P. Llebrez-Zayas, E. Matas-Rico, L. Santín, C. Pedraza, I. De Diego, I. Del Arco, P. Fernández- Llebrez, J. Chun, and F. R. De Fonseca. 2008. Absence of LPA1 signaling results in defective cortical development. Cereb. Cortex 18: 938-950. (Pubitemid 351398359)
18. Skoura, A., and T. Hla. 2009. Lysophospholipid receptors in vertebrate development, physiology and pathology. J. Lipid Res. 50(Suppl.): S293-S298.
19. Fukushima, N. 2004. LPA in neural cell development. J. Cell. Biochem. 92: 993-1003. (Pubitemid 44264246)
20. Saba, J. D. 2004. Lysophospholipids in development: Miles apart and edging in. J. Cell. Biochem. 92: 967-992. (Pubitemid 44264245)
21. Mills, G. B., A. Eder, X. Fang, Y. Hasegawa, M. Mao, Y. Lu, J. Tanyi, F. H. Tabassam, J. Wiener, R. Lapushin, et al. 2002. Critical role of lysophospholipids in the pathophysiology, diagnosis, and management of ovarian cancer. Cancer Treat. Res. 107: 259-283.
22. Zhang, C., D. L. Baker, S. Yasuda, N. Makarova, L. Balazs, L. R. Johnson, G. K. Marathe, T. M. McIntyre, Y. Xu, G. D. Prestwich, et al. 2004. Lysophosphatidic acid induces neointima formation through PPARgamma activation. J. Exp. Med. 199: 763-774. (Pubitemid 38375196)
23. Panchatcharam, M., S. Miriyala, F. Yang, M. Rojas, C. End, C. Vallant, A. Dong, K. Lynch, J. Chun, A. J. Morris, and S. S. Smyth. 2008. Lysophosphatidic acid receptors 1 and 2 play roles in regulation of vascular injury responses but not blood pressure. Circ. Res. 103: 662-670.
24. Rahaman, M., R. W. Costello, K. E. Belmonte, S. S. Gendy, and M. T. Walsh. 2006. Neutrophil sphingosine 1-phosphate and lysophosphatidic acid receptors in pneumonia. Am. J. Respir. Cell Mol. Biol. 34: 233-241. (Pubitemid 43202471)
25. Tager, A. M., P. LaCamera, B. S. Shea, G. S. Campanella, M. Selman, Z. Zhao, V. Polosukhin, J. Wain, B. A. Karimi-Shah, N. D. Kim, et al. 2008. The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak. Nat. Med. 14: 45-54.
26. Xu, M. Y., J. Porte, A. J. Knox, P. H. Weinreb, T. M. Maher, S. M. Violette, R. J. McAnulty, D. Sheppard, and G. Jenkins. 2009. Lysophosphatidic acid induces alphavbeta6 integrin-mediated TGF-beta activation via the LPA2 receptor and the small G protein G alpha(q). Am. J. Pathol. 174: 1364-1279.
27. Hashimoto, T., M. Yamashita, H. Ohata, and K. Momose. 2003. Lysophosphatidic acid enhances in vivo infiltration and activation of guinea pig eosinophils and neutrophils via a Rho/Rho-associated protein kinase-mediated pathway. J. Pharmacol. Sci. 91: 8-14. (Pubitemid 36575549)
28. Cummings, R., Y. Zhao, D. Jacoby, E. W. Spannhake, M. Ohba, J. G. Garcia, T. Watkins, D. He, B. Saatian, and V. Natarajan. 2004. Protein kinase Cdelta mediates lysophosphatidic acid-induced NF-kappaB activation and interleukin-8 secretion in human bronchial epithelial cells. J. Biol. Chem. 279: 41085-41094. (Pubitemid 39287710)
29. Medoff, B. D., A. L. Landry, K. A. Wittbold, B. P. Sandall, M. C. Derby, Z. Cao, J. C. Adams, and R. J. Xavier. 2009. CARMA3 mediates lysophosphatidic acidstimulated cytokine secretion by bronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 40: 286-294.
30. Toews, M. L., E. E. Ustinova, and H. D. Schultz. 1997. Lysophosphatidic acid enhances contractility of isolated airway smooth muscle. J. Appl. Physiol. 83: 1216-1222. (Pubitemid 27433090)
31. Tatler, A. L., A. E. John, L. Jolly, A. Habgood, J. Porte, C. Brightling, A. J. Knox, L. Pang, D. Sheppard, X. Huang, and G. Jenkins. 2011. Integrin avb5-mediated TGF-β activation by airway smooth muscle cells in asthma. J. Immunol. 187: 6094-6107.
32. Georas, S. N. 2009. Lysophosphatidic acid and autotaxin: emerging roles in innate and adaptive immunity. Immunol Res. 45: 229-238.
33. Kanda, H., R. Newton, R. Klein, Y. Morita, M. D. Gunn, and S. D. Rosen. 2008. Autotaxin, an ectoenzyme that produces lysophosphatidic acid, promotes the entry of lymphocytes into secondary lymphoid organs. Nat. Immunol. 9: 415-423. (Pubitemid 351405111)
34. Fan, H., B. Zingarelli, V. Harris, G. E. Tempel, P. V. Halushka, and J. A. Cook. 2008. Lysophosphatidic acid inhibits bacterial endotoxin-induced proinflammatory response: potential anti-inflammatory signaling pathways. Mol. Med. 14: 422-428.
35. Chen, R., J. Roman, J. Guo, E. West, J. McDyer, M. A. Williams, and S. N. Georas. 2006. Lysophosphatidic acid modulates the activation of human monocyte-derived dendritic cells. Stem Cells Dev. 15: 797-804. (Pubitemid 46147852)
36. Williams, M. A., T. Rangasamy, S. M. Bauer, S. Killedar, M. Karp, T. W. Kensler, M. Yamamoto, P. Breysse, S. Biswal, and S. N. Georas. 2008. Disruption of the transcription factor Nrf2 promotes pro-oxidative dendritic cells that stimulate Th2-like immunoresponsiveness upon activation by ambient particulate matter. J. Immunol. 181: 4545-4559.
37. Guo, J., X. Lin, M. A. Williams, Q. Hamid, and S. N. Georas. 2008. Yin-Yang 1 regulates effector cytokine gene expression and T(H)2 immune responses. J. Allergy Clin. Immunol. 122: 195-201, 201.e1-5.
38. Ohta, H., K. Sato, N. Murata, A. Damirin, E. Malchinkhuu, J. Kon, T. Kimura, M. Tobo, Y. Yamazaki, T. Watanabe, et al. 2003. Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors. Mol. Pharmacol. 64: 994-1005. (Pubitemid 37153068)
39. Chan, L. C., W. Peters, Y. Xu, J. Chun, R. V. Farese, Jr., and S. Cases. 2007. LPA3 receptor mediates chemotaxis of immature murine dendritic cells to unsaturated lysophosphatidic acid (LPA). J. Leukoc. Biol. 82: 1193-1200. (Pubitemid 350133517)
40. Wills-Karp, M., J. Luyimbazi, X. Xu, B. Schofield, T. Y. Neben, C. L. Karp, and D. D. Donaldson. 1998. Interleukin-13: central mediator of allergic asthma. Science 282: 2258-2261. (Pubitemid 29004074)
41. Lee, C. G., H. Link, P. Baluk, R. J. Homer, S. Chapoval, V. Bhandari, M. J. Kang, L. Cohn, Y. K. Kim, D. M. McDonald, and J. A. Elias. 2004. Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung. Nat. Med. 10: 1095-1103. (Pubitemid 39424871)
42. Sung, S., C. E. Rose, and S. M. Fu. 2001. Intratracheal priming with ovalbuminand ovalbumin 323-339 peptide-pulsed dendritic cells induces airway hyperresponsiveness, lung eosinophilia, goblet cell hyperplasia, and inflammation. J. Immunol. 166: 1261-1271. (Pubitemid 32060287)
43. Kuipers, H., T. Soullié, H. Hammad, M. Willart, M. Kool, D. Hijdra, H. C. Hoogsteden, and B. N. Lambrecht. 2009. Sensitization by intratracheally injected dendritic cells is independent of antigen presentation by host antigenpresenting cells. J. Leukoc. Biol. 85: 64-70.
44. Koya, T., H. Matsuda, S. Matsubara, N. Miyahara, A. Dakhama, K. Takeda, and E. W. Gelfand. 2009. Differential effects of dendritic cell transfer on airway hyperresponsiveness and inflammation. Am. J. Respir. Cell Mol. Biol. 41: 271-280.
45. Eisenbarth, S. C., D. A. Piggott, J. W. Huleatt, I. Visintin, C. A. Herrick, and K. Bottomly. 2002. Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J. Exp. Med. 196: 1645-1651. (Pubitemid 36026476)
46. Liew, F. Y., D. Xu, E. K. Brint, and L. A. O'Neill. 2005. Negative regulation of toll-like receptor-mediated immune responses. Nat. Rev. Immunol. 5: 446-458. (Pubitemid 40835033)
47. Kawai, T., and S. Akira. 2010. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 11: 373-384.
48. Block, R. C., R. Duff, P. Lawrence, L. Kakinami, J. T. Brenna, G. C. Shearer, N. Meednu, S. Mousa, A. Friedman, W. S. Harris, et al. 2010. The effects of EPA, DHA, and aspirin ingestion on plasma lysophospholipids and autotaxin. Prostaglandins Leukot. Essent. Fatty Acids 82: 87-95.
49. Georas, S. N., E. Berdyshev, W. Hubbard, I. A. Gorshkova, P. V. Usatyuk, B. Saatian, A. C. Myers, M. A. Williams, H. Q. Xiao, M. Liu, and V. Natarajan. 2007. Lysophosphatidic acid is detectable in human bronchoalveolar lavage fluids at baseline and increased after segmental allergen challenge. Clin. Exp. Allergy 37: 311-322. (Pubitemid 46393233)
50. Serhan, C. N., N. Chiang, and T. E. Van Dyke. 2008. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat. Rev. Immunol. 8: 349-361. (Pubitemid 351595216)
51. He, D., Y. Su, P. V. Usatyuk, E. W. Spannhake, P. Kogut, J. Solway, V. Natarajan, and Y. Zhao. 2009. Lysophosphatidic acid enhances pulmonary epithelial barrier integrity and protects endotoxin-induced epithelial barrier disruption and lung injury. J. Biol. Chem. 284: 24123-24132.
52. Ausiello, C. M., G. Fedele, F. Urbani, R. Lande, B. Di Carlo, and A. Cassone. 2002. Native and genetically inactivated pertussis toxins induce human dendritic cell maturation and synergize with lipopolysaccharide in promoting T helper type 1 responses. J. Infect. Dis. 186: 351-360. (Pubitemid 34816318)
53. Shuyu, E., Y. J. Lai, R. Tsukahara, C. S. Chen, Y. Fujiwara, J. Yue, J. H. Yu, H. Guo, A. Kihara, G. Tigyi, and F. T. Lin. 2009. Lysophosphatidic acid 2 receptormediated supramolecular complex formation regulates its antiapoptotic effect. J. Biol. Chem. 284: 14558-14571.
54. Zhao, Y., J. Tong, D. He, S. Pendyala, B. Evgeny, J. Chun, A. I. Sperling, and V. Natarajan. 2009. Role of lysophosphatidic acid receptor LPA2 in the development of allergic airway inflammation in a murine model of asthma. Respir. Res. 10: 114.
55. Rubenfeld, J., J. Guo, N. Sookrung, R. Chen, W. Chaicumpa, V. Casolaro, Y. Zhao, V. Natarajan, and S. Georas. 2006. Lysophosphatidic acid enhances interleukin-13 gene expression and promoter activity in T cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 290: L66-L74.
56. Zhao, Y., D. He, J. Zhao, L. Wang, A. R. Leff, E. W. Spannhake, S. Georas, and V. Natarajan. 2007. Lysophosphatidic acid induces interleukin-13 (IL-13) receptor alpha2 expression and inhibits IL-13 signaling in primary human bronchial epithelial cells. J. Biol. Chem. 282: 10172-10179. (Pubitemid 47093444)
57. Matsuzaki, S., T. Ishizuka, T. Hisada, H. Aoki, M. Komachi, I. Ichimonji, M. Utsugi, A. Ono, Y. Koga, K. Dobashi, et al. 2010. Lysophosphatidic acid inhibits CC chemokine ligand 5/RANTES production by blocking IRF-1mediated gene transcription in human bronchial epithelial cells. J. Immunol. 185: 4863-4872.
58. Cerutis, D. R., M. Nogami, J. L. Anderson, J. D. Churchill, D. J. Romberger, S. I. Rennard, and M. L. Toews. 1997. Lysophosphatidic acid and EGF stimulate mitogenesis in human airway smooth muscle cells. Am. J. Physiol. 273: L10-L15.